Britain’s GSK to buy Affinivax for up to $3.3 billion in vaccines push
GSK, the world’s largest vaccine maker by sales, has been under pressure to shore up its pipeline
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
GSK
Aleor Dermaceuticals receives US FDA final approval for Docosanol cream
Docosanol Cream, 10% (OTC) is used for cold sore/fever blisters on the face or lips
GSK and SK bioscience’s COVID vaccine submitted for S Korea approval
GSK said that SK bioscience will also apply to WHO for EUL and seek authorisations at individual regulatory agencies around the…
GSK launches once daily, Single Inhaler-Triple Therapy for COPD patients
The launch follows the product’s approval by the Drugs Controller General of India (DCGI) for use of Trelegy Ellipta as…
GSK to acquire Sierra Oncology to shore up drug pipeline
The acquisition is expected to close in the third quarter and will complement Blenrep, GSK’s treatment for another form of blood…
Germany agrees deal with CureVac, GSK for mRNA vaccines until 2029
The five-year contract allows for production of up to 80 million doses at short notice until 2029, CureVac said, adding that those…
FDA says current dose of GSK, Vir COVID therapy likely not effective against BA.2 variant
The FDA’s move comes as a blow to the companies which have seen high demand for Sotrovimab after it became one of the few COVID-19…
Drugmakers and scientists begin hunt for long COVID treatments
Researchers, biotech companies and public health experts say major pharma companies are integral to getting a proven treatment for…
GSK announces appointments to designate Haleon Board
Demerger and listing of Haleon is expected in July 2022
GSK provides update on phase-III RSV maternal vaccine candidate
The company has decided to stop enrollment and vaccination in trials evaluating its potential Respiratory Syncytial Virus (RSV)…